Beta Bionics, Inc./$BBNX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Beta Bionics, Inc.
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.
Ticker
$BBNX
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
353
ISIN
US08659B1026
Website
BBNX Metrics
BasicAdvanced
$848M
-
-$5.66
-
-
Price and volume
Market cap
$848M
52-week high
$21.62
52-week low
$8.89
Average daily volume
530K
Financial strength
Current ratio
15.881
Quick ratio
14.585
Long term debt to equity
1.737
Total debt to equity
2.223
Management effectiveness
Valuation
Price to revenue (TTM)
3.51
Price to book
2.7
Price to tangible book (TTM)
2.7
Price to free cash flow (TTM)
-4.125
Growth
BBNX News
AllArticlesVideos
Beta Bionics to Host Investor Event on June 22, 2025
GlobeNewsWire·2 months ago
Beta Bionics Announces Board Appointment of Gerard Michel
GlobeNewsWire·2 months ago
Beta Bionics Announces Fourth Quarter and Full Year 2024 Financial Results and Introduces Annual Guidance for Full Year 2025
GlobeNewsWire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Beta Bionics, Inc. stock?
Beta Bionics, Inc. (BBNX) has a market cap of $848M as of June 07, 2025.
What is the P/E ratio for Beta Bionics, Inc. stock?
The price to earnings (P/E) ratio for Beta Bionics, Inc. (BBNX) stock is 0 as of June 07, 2025.
Does Beta Bionics, Inc. stock pay dividends?
No, Beta Bionics, Inc. (BBNX) stock does not pay dividends to its shareholders as of June 07, 2025.
When is the next Beta Bionics, Inc. dividend payment date?
Beta Bionics, Inc. (BBNX) stock does not pay dividends to its shareholders.
What is the beta indicator for Beta Bionics, Inc.?
Beta Bionics, Inc. (BBNX) does not currently have a Beta indicator.